# Hellenic Society of Medical Oncology

> organisation involved in scholarly research

**Wikidata**: [Q74543941](https://www.wikidata.org/wiki/Q74543941)  
**Source**: https://4ort.xyz/entity/hellenic-society-of-medical-oncology

## Summary
The Hellenic Society of Medical Oncology is a research institute dedicated to scholarly work in the field of medical oncology. It is classified as an organization focused on research, with a specific emphasis on clinical oncology, and is recognized in academic and funding contexts. Despite its name suggesting a connection to Greece, available data indicates it is associated with Poland.

## Key Facts
- **Instance of**: Research institute, with a qualifier noting its relation to the "Forum of clinical oncology".
- **Country**: Poland (per provided source material).
- **Open Funder Registry ID**: 501100010355.
- **Wikidata Description**: Organisation involved in scholarly research.
- **Related Class**: Categorized under "research institute" with 41 sitelinks.
- **Reference Source**: Documentation includes a reference to De Gruyter's author guidelines.

## FAQs
### Q: Where is the Hellenic Society of Medical Oncology based?
A: The provided data lists its country as Poland, though its name suggests a Greek connection. This discrepancy may reflect an error in the source material.

### Q: What is the primary focus of the organization?
A: It is a research institute centered on medical oncology, particularly clinical oncology, as indicated by its qualifier.

### Q: Is the organization a recognized funding body?
A: Yes, it has an Open Funder Registry ID (501100010355), signifying its role in research funding.

## Why It Matters
The Hellenic Society of Medical Oncology contributes to advancing medical oncology through scholarly research and clinical focus. As a recognized research institute with a dedicated funder ID, it plays a role in supporting studies and academic initiatives in the field. Its association with the "Forum of clinical oncology" highlights its engagement with professional and academic networks, fostering collaboration and knowledge-sharing among oncology professionals. Despite potential ambiguities in its geographic affiliation, the organization’s structured presence in academic references underscores its legitimacy and impact within oncology research.

## Notable For
- Recognized research institute with a specific focus on clinical oncology.
- Holds an Open Funder Registry ID, indicating its role in funding research.
- Associated with the "Forum of clinical oncology," emphasizing its clinical and academic orientation.
- Categorized under "research institute" with cross-references in academic publishing guidelines.

## Body
### Organization Type
The Hellenic Society of Medical Oncology is formally classified as a **research institute**, with its primary purpose being scholarly activity in medical oncology. This classification is supported by its instance-of statement and related references.

### Geographic Affiliation
Data provided lists **Poland** as the associated country, referenced via Wikidata (P887: Q69652283). This detail may require verification due to the "Hellenic" name typically implying Greece.

### Research Focus
The organization’s work is explicitly tied to the **"Forum of clinical oncology"**, as noted in qualifiers. This connection positions it within a network focused on clinical aspects of oncology, including research dissemination and professional dialogue.

### Funding and Identification
With an **Open Funder Registry ID (501100010355)**, the society is recognized as a funding entity in academic and research contexts. This identifier is critical for tracking its contributions to studies and initiatives in oncology.

### Academic References
Documentation cites De Gruyter’s author guidelines, linking the organization to publication processes in academic journals. This reinforces its role in supporting and conducting research that meets scholarly standards.

## References

1. [Directory of Open Access Journals](http://www.degruyter.com/view/supplement/s1792362X_Author_Guidelines.pdf)